Back

Combination therapy with SGLT2 inhibitor and beta-blocker in patients with HFpEF and atrial fibrillation: impact on nt-proBNP, HS-CRP, e/e′ and functional capacity

2 June 2025 (18:27 - 18:29)
Organised by: Logo
Seminar Presentation Part of: Poster rapid fire session Heart Failure Delegate Premium access CBCS Summer School 2025 Council on Basic Cardiovascular Science

About the speaker

Photo
Doctor Veneta Dimitrova

University Hospital Alexandrovska, Sofia (Bulgaria)

24 More presentations in this session

Presentation thumbnail
Targeting wild-type transthyretin aggregation: vovel stabilizers to mitigate cardiomyocyte dysfunction in aging
Doctor L. Russo (Pisa, IT)
Slides
Presentation thumbnail
Role of inflammation and macrophages in the formation of the atrial cardiomyopathy associated with obesity
Mrs N. Suffee (Paris, FR)
Slides
Presentation thumbnail
Mapping the mechanical landscape of the heart: major sarcomere protein contributions to myocardial passive stiffness along two axes.
Mr F. Wagner (Munster, DE)
Slides
Presentation thumbnail
Emerging role of IL-11-driven microRNAs in cardiac fibrosis
Ms V. Boichenko (Verona, IT)
Slides
Presentation thumbnail
Pathophysiology of dialysis-induced arrhythmogenesis
Mr V. Melenovsky (Prague, CZ)
Slides

Access the full session

Session thumbnail
Poster rapid fire session

The Event

Event poster

CBCS Summer School 2025

2 June 2025 18:27 CET

ESC 365 is supported by

novartis Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources